11 – 20 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Performance of [18F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy
- Contribution to journal › Article
- 2022
-
Mark
Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data
- Contribution to journal › Article
-
Mark
A relatively common hypomorphic variant in WARS2 causes monogenic disease
- Contribution to journal › Debate/Note/Editorial
-
Mark
Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients
- Contribution to journal › Article
- 2021
-
Mark
Digital health technology for non-motor symptoms in people with Parkinson's disease : Futile or future?
- Contribution to journal › Scientific review
-
Mark
Validation and clinical value of the MANAGE-PD tool : A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
- Contribution to journal › Article
-
Mark
The neurological and neuropsychiatric spectrum of adults with late-treated phenylketonuria
- Contribution to journal › Article
-
Mark
Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patients
- Contribution to journal › Article
- 2020
-
Mark
A detailed description of the phenotypic spectrum of North Sea Progressive Myoclonus Epilepsy in a large cohort of seventeen patients
- Contribution to journal › Article
-
Mark
New generation genetic testing entering the clinic
- Contribution to journal › Article
